Clinical Trials List
2025-09-22 - 2029-03-18
Recruiting9
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Seu-Chun Yang 無
- Po-Lan Su 無
- 黃怡璇 無
- 鍾秉軒 無
- Shang-Yin Wu
- 黃怡菁
- 蔡政軒 無
- Chin-Wei Kuo
- Yu-Min Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱立忠 無
- Jia-Shiuan Ju 無
- 枋岳甫 無
- Chih-Hung Chen 無
- Ching-His Siao 無
- 林定佑 無
- Chih-Liang Wang 無
- Shih-Hong Li 無
- Wen-Cheng Chang 無
- Cheng-Ta Yang 無
- 吳教恩 無
- Ping-Chih Hsu 無
- 黃振洋 無
- 吳振德 無
- 柯皓文 無
- 黃宗楨 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JIN-YUAN SHIH 無
- 蔡子修 無
- 林昭文 無
- Jih-Hsiang Lee 無
- 楊景堯 無
- YEN-TING LIN 無
- James Chih-Hsin Yang 無
- 吳尚俊 無
- 徐偉勛 無
- 廖斌志 無
- CHAO-CHI HO CHAO-CHI HO 無
- 黃俊凱 無
- 錢穎群 無
- Chia-Chi Lin 無
- 許嘉林 無
- 陳冠宇 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yuh-Min Chen 無
- 蕭慈慧 無
- Chi-Lu Chiang 無
- Hsu-ching Huang 無
- 廖映庭 無
- 張毓帆 無
- 趙恒勝 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Yen Tu 無
- Chia-Hsiang Li 無
- 陳鴻仁 無
- Yu-Chao Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
278 participants
